Arvinas. has been granted a patent for ultra-pure forms and formulations of Compound A, a therapeutic agent potentially effective against cancer. The patent includes methods for manufacturing and purifying this compound, as well as its crystalline form. GlobalData’s report on Arvinas gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Arvinas, Cancer treatment biomarkers was a key innovation area identified from patents. Arvinas's grant share as of June 2024 was 22%. Grant share is based on the ratio of number of grants to total number of patents.
Crystalline form of compound a for therapeutic use
The granted patent US12043612B2 pertains to a crystalline form of Compound A, detailing various specific characteristics of this compound. The claims outline multiple crystalline forms, with a focus on Form 2, which is defined by the presence of distinct peaks at specific angles measured in degrees 2?. The first claim establishes the existence of a crystalline form of Compound A, while subsequent claims specify additional peaks at 11.30±0.2°, 17.2°±0.2°, and 7.9°±0.2° 2?, indicating a method for characterizing the crystalline structure of the compound.
Further claims elaborate on Form 2 of Compound A, identifying additional peaks at 18.5°±0.2°, 21.4°±0.2°, and 3.2°±0.2° 2?. These claims emphasize the structural uniqueness of Form 2, with multiple references to the same peak angles across different claims, suggesting a detailed and systematic approach to defining the crystalline forms. The specificity of the angles and the precision in the measurements highlight the importance of these characteristics in the identification and potential applications of Compound A in various fields, including pharmaceuticals and materials science.
To know more about GlobalData’s detailed insights on Arvinas, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
